Showing 5 Result(s)
Image Description: Brown & Cream Coloured Image Depicting a Typewriter With Wording "Antidepressants". Typed On Paper. Image Credit: PhotoFunia.com Category: Vintage Typewriter.

Overprescribing Anti-Depressants: The Good, The Bad and the Ugly

Antidepressant use has soared over the past two decades, with the UK alone seeing a doubling in prescriptions since 2008. While medication can be life-changing for some, concerns are growing around its overprescription, especially for patients who may not need long-term pharmacological treatment. From the reluctance of GPs to offer fast-acting relief to the alarming trend of children being medicated, it’s time to ask, are we medicating emotion at the expense of wellbeing?

Image Description: Brown & Cream Coloured Image Depicting a Typewriter With Wording "Microbiome Gut Bacteria". Typed On Paper. Image Credit: PhotoFunia.com Category: Vintage Typewriter.

Understanding the Microbiome, Gut Bacteria

The human microbiome refers to the trillions of microorganisms—bacteria, viruses, fungi, and protozoa—that live on and inside the body. The gut microbiome, in particular, plays a crucial role in digestion, immune function, and even brain chemistry. Research is rapidly uncovering how this “second brain” in the gut communicates with our actual brain and influences physical and mental well-being.

Professor Neil Robertson: Leading Neurologist and Researcher

Professor Neil Robertson’s contributions to neurology and neurological research have not only advanced our understanding of complex disorders like multiple sclerosis but also shaped the landscape of neurological healthcare in Wales and beyond. His research and clinical work represent a commitment to both scientific discovery and compassionate care, offering hope to patients and families affected by neurological conditions. As he continues to lead new studies and mentor future neurologists, his impact will undoubtedly continue to be felt across the fields of neurology, genetics, and patient advocacy.

Progressive Multifocal Leukoencephalopathy (PML)

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.